The most important biological function of exosomes is their possible use as biomarkers in
clinical diagnosis. Compared with biomarkers identified in conventional specimens such as …

Introduction: Pancreatic cancer has the worst survival rate of all cancers. The current
standard care for metastatic pancreatic cancer is gemcitabine, however, the success of this …

Background: The neutrophil-lymphocyte ratio (NLR) has been proposed as an indicator of
systemic inflammatory response. Previous findings from small-scale studies revealed …

Background The EUROCARE study collects and analyses survival data from population-
based cancer registries (CRs) in Europe in order to provide data on between-country …

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer-related death
worldwide. Gemcitabine is the mainstay treatment for advanced disease. However, almost …

Background: The association between pancreatic ductal adenocarcinoma (PDAC) location
(head, body, tail) and tumor stage, treatment and overall survival (OS) is unclear. Methods …

Abstract Background and Aim: This study investigated whether diabetes mellitus (DM)
increased the risk of pancreatic cancer and whether anti‐diabetic drugs reduced the risk in …

Objectives Survival improvement for pancreatic cancer has not been observed in the last 4
decades. We report the most up-to-date population-based relative survival (RS) estimates …

The efficacy of current treatment regimens for pancreatic cancer (PC) remains unsatisfactory.
In recent years, immune checkpoint blockade (ICB) therapy has shown promising anti-tumor …

Pancreatic survival is one of the worst in oncology. To what extent wait times affect outcomes
in unknown No population‐based study has previously explored patient and treatment …